Intraoperative radiation therapy for advanced cervical metastasis: A single institution experience

Youssef Zeidan, Alex Yeh, Daniel Weed, Colin Terry, Stephen Freeman, Edward Krowiak, Robert Borrowdale, Tod Huntley

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Background: The purpose of this study is to review our experience with the use of IORT for patients with advanced cervical metastasis.Methods: Between August 1982 and July 2007, 231 patients underwent neck dissections as part of initial therapy or as salvage treatment for advanced cervical node metastases resulting from head and neck malignancies. IORT was administered as a single fraction to a dose of 15 Gy or 20 Gy in most pts. The majority was treated with 5 MeV electrons (112 pts, 50.5%).Results: 1, 3, and 5 years overall survival (OS) after surgery + IORT was 58%, 34%, and 26%, respectively. Recurrence-free survival (RFS) at 1, 3, and 5 years was 66%, 55%, and 49%, respectively. Disease recurrence was documented in 83 (42.8%) pts. The majority of recurrences were regional (38 pts), as compared to local recurrence in 20 pts and distant failures in 25 pts. There were no perioperative fatalities.Conclusions: IORT results in effective local disease control at acceptable levels of toxicity. Our results support the initiation of a phase III trial comparing outcomes for patients with cervical metastasis treated with or without IORT.

Original languageEnglish (US)
Article number72
JournalRadiation Oncology
Volume6
Issue number1
DOIs
StatePublished - Jun 15 2011
Externally publishedYes

Fingerprint

Radiotherapy
Neoplasm Metastasis
Recurrence
Salvage Therapy
Neck Dissection
Survival
Neck
Head
Electrons
Neoplasms
Therapeutics

Keywords

  • Cervical metastasis
  • Intraoperative radiotherapy
  • IORT

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Medicine(all)

Cite this

Zeidan, Y., Yeh, A., Weed, D., Terry, C., Freeman, S., Krowiak, E., ... Huntley, T. (2011). Intraoperative radiation therapy for advanced cervical metastasis: A single institution experience. Radiation Oncology, 6(1), [72]. https://doi.org/10.1186/1748-717X-6-72

Intraoperative radiation therapy for advanced cervical metastasis : A single institution experience. / Zeidan, Youssef; Yeh, Alex; Weed, Daniel; Terry, Colin; Freeman, Stephen; Krowiak, Edward; Borrowdale, Robert; Huntley, Tod.

In: Radiation Oncology, Vol. 6, No. 1, 72, 15.06.2011.

Research output: Contribution to journalArticle

Zeidan, Y, Yeh, A, Weed, D, Terry, C, Freeman, S, Krowiak, E, Borrowdale, R & Huntley, T 2011, 'Intraoperative radiation therapy for advanced cervical metastasis: A single institution experience', Radiation Oncology, vol. 6, no. 1, 72. https://doi.org/10.1186/1748-717X-6-72
Zeidan, Youssef ; Yeh, Alex ; Weed, Daniel ; Terry, Colin ; Freeman, Stephen ; Krowiak, Edward ; Borrowdale, Robert ; Huntley, Tod. / Intraoperative radiation therapy for advanced cervical metastasis : A single institution experience. In: Radiation Oncology. 2011 ; Vol. 6, No. 1.
@article{9c39c79b9e1a4af2a3c3463e1cec30d6,
title = "Intraoperative radiation therapy for advanced cervical metastasis: A single institution experience",
abstract = "Background: The purpose of this study is to review our experience with the use of IORT for patients with advanced cervical metastasis.Methods: Between August 1982 and July 2007, 231 patients underwent neck dissections as part of initial therapy or as salvage treatment for advanced cervical node metastases resulting from head and neck malignancies. IORT was administered as a single fraction to a dose of 15 Gy or 20 Gy in most pts. The majority was treated with 5 MeV electrons (112 pts, 50.5{\%}).Results: 1, 3, and 5 years overall survival (OS) after surgery + IORT was 58{\%}, 34{\%}, and 26{\%}, respectively. Recurrence-free survival (RFS) at 1, 3, and 5 years was 66{\%}, 55{\%}, and 49{\%}, respectively. Disease recurrence was documented in 83 (42.8{\%}) pts. The majority of recurrences were regional (38 pts), as compared to local recurrence in 20 pts and distant failures in 25 pts. There were no perioperative fatalities.Conclusions: IORT results in effective local disease control at acceptable levels of toxicity. Our results support the initiation of a phase III trial comparing outcomes for patients with cervical metastasis treated with or without IORT.",
keywords = "Cervical metastasis, Intraoperative radiotherapy, IORT",
author = "Youssef Zeidan and Alex Yeh and Daniel Weed and Colin Terry and Stephen Freeman and Edward Krowiak and Robert Borrowdale and Tod Huntley",
year = "2011",
month = "6",
day = "15",
doi = "10.1186/1748-717X-6-72",
language = "English (US)",
volume = "6",
journal = "Radiation Oncology",
issn = "1748-717X",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Intraoperative radiation therapy for advanced cervical metastasis

T2 - A single institution experience

AU - Zeidan, Youssef

AU - Yeh, Alex

AU - Weed, Daniel

AU - Terry, Colin

AU - Freeman, Stephen

AU - Krowiak, Edward

AU - Borrowdale, Robert

AU - Huntley, Tod

PY - 2011/6/15

Y1 - 2011/6/15

N2 - Background: The purpose of this study is to review our experience with the use of IORT for patients with advanced cervical metastasis.Methods: Between August 1982 and July 2007, 231 patients underwent neck dissections as part of initial therapy or as salvage treatment for advanced cervical node metastases resulting from head and neck malignancies. IORT was administered as a single fraction to a dose of 15 Gy or 20 Gy in most pts. The majority was treated with 5 MeV electrons (112 pts, 50.5%).Results: 1, 3, and 5 years overall survival (OS) after surgery + IORT was 58%, 34%, and 26%, respectively. Recurrence-free survival (RFS) at 1, 3, and 5 years was 66%, 55%, and 49%, respectively. Disease recurrence was documented in 83 (42.8%) pts. The majority of recurrences were regional (38 pts), as compared to local recurrence in 20 pts and distant failures in 25 pts. There were no perioperative fatalities.Conclusions: IORT results in effective local disease control at acceptable levels of toxicity. Our results support the initiation of a phase III trial comparing outcomes for patients with cervical metastasis treated with or without IORT.

AB - Background: The purpose of this study is to review our experience with the use of IORT for patients with advanced cervical metastasis.Methods: Between August 1982 and July 2007, 231 patients underwent neck dissections as part of initial therapy or as salvage treatment for advanced cervical node metastases resulting from head and neck malignancies. IORT was administered as a single fraction to a dose of 15 Gy or 20 Gy in most pts. The majority was treated with 5 MeV electrons (112 pts, 50.5%).Results: 1, 3, and 5 years overall survival (OS) after surgery + IORT was 58%, 34%, and 26%, respectively. Recurrence-free survival (RFS) at 1, 3, and 5 years was 66%, 55%, and 49%, respectively. Disease recurrence was documented in 83 (42.8%) pts. The majority of recurrences were regional (38 pts), as compared to local recurrence in 20 pts and distant failures in 25 pts. There were no perioperative fatalities.Conclusions: IORT results in effective local disease control at acceptable levels of toxicity. Our results support the initiation of a phase III trial comparing outcomes for patients with cervical metastasis treated with or without IORT.

KW - Cervical metastasis

KW - Intraoperative radiotherapy

KW - IORT

UR - http://www.scopus.com/inward/record.url?scp=79958765457&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958765457&partnerID=8YFLogxK

U2 - 10.1186/1748-717X-6-72

DO - 10.1186/1748-717X-6-72

M3 - Article

C2 - 21676211

AN - SCOPUS:79958765457

VL - 6

JO - Radiation Oncology

JF - Radiation Oncology

SN - 1748-717X

IS - 1

M1 - 72

ER -